Design Therapeutics, Inc.DSGNNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-7.30%
↓ 132% below average
Average (22q)
22.59%
Historical baseline
Range
High:181.43%
Low:-22.31%
Volatility
901.8%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -7.30% |
| Q2 2025 | 2.35% |
| Q1 2025 | 26.49% |
| Q4 2024 | 2.37% |
| Q3 2024 | 14.58% |
| Q2 2024 | 7.32% |
| Q1 2024 | -12.30% |
| Q4 2023 | -16.93% |
| Q3 2023 | -22.31% |
| Q2 2023 | 8.48% |
| Q1 2023 | 10.35% |
| Q4 2022 | -0.34% |
| Q3 2022 | 26.64% |
| Q2 2022 | 28.95% |
| Q1 2022 | 19.38% |
| Q4 2021 | -14.08% |
| Q3 2021 | 69.86% |
| Q2 2021 | 29.73% |
| Q1 2021 | 43.09% |
| Q4 2020 | 41.48% |
| Q3 2020 | 80.40% |
| Q2 2020 | 181.43% |
| Q1 2020 | 0.00% |